Status:
COMPLETED
CT-DSA Evaluation of Embolization in Debulking Spinal Surgery
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Spinal Metastases
Surgery
Eligibility:
All Genders
20+ years
Brief Summary
Vertebra is one of the most common site of metastatic disease, which may cause severe pain or neurological deficit. Decompressive surgery or radiation therapy are of limited efficacy and recurrence is...
Detailed Description
Vertebral osseus metastasis, can cause neoplastic spinal cord compression and neurological deficit. The treatment strategy depend on the pathological type, performance status, and life expectancy. The...
Eligibility Criteria
Inclusion
- Patient with clinical diagnosis for thoracolumbar vertebral primary or metastatic malignancy
- Eligible for aggressive spinal surgery, including debulking and en bloc spondylectomy
- Life expectancy more than 6 months
- Serum creatinine less than 1.5 mg/dL
Exclusion
- Age less than 20 year old
- Woman in pregnancy or breast feeding
- Serious allergic reaction to contrast medium
- Instable neurological condition warrant urgent operation
Key Trial Info
Start Date :
August 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04497051
Start Date
August 18 2020
End Date
March 31 2023
Last Update
May 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan